Investornewsbreaks Silo Pharma Inc. (NASDAQ: SILO) Begins Final Preclinical Study For PTSD ...
Silo Pharma (NASDAQ: SILO) announced the first dosing in a GLP-compliant toxicology and toxicokinetics study for its lead candidate, SPC-15, an intra ...
Silo Pharma announces first dosing in IND-enabling study for SPC-15
Silo Pharma (SILO) announced first dosing in an investigational new drug-enabling GLP-compliant toxicology and toxicokinetics study of its lead ...
Silo Pharma Achieves Key Milestone with First Dosing in IND-Enabling GLP Study for SPC-15 ...
Preclinical Data to Support Advancement Toward First-in-Human Clinical Trials SARASOTA, FL, March 26, 2025 (GLOBE NEWSWIRE) - ...
thenewsgod5 天
Trump administration slashes federal funding for ‘transgender animal’ experiments
President Donald Trump's National Institute of Health slashed over $1 million in federally funded research evaluating if rats ...
Trump admin cuts additional $1M in federal funding for 'transgender animal' experiments
The National Institute of Health quietly cut over $1 million in federally funded research evaluating if rats going through ...
Frontiers1 年
Toxicokinetics of recombinant human fibroblast growth factor 21 for injection in cynomolgus ...
However, little is known about the toxicokinetic characteristics of FGF-21. Methods: In the present study, we investigated the toxicokinetics of FGF-21 delivered via subcutaneous injection in vivo.